Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis

References

• HeYYYanYZhangHFMethyl salicylate 2-O-β-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transductionDrug Des Devel Ther20161031833196
   PubMed Web of Science ®Google Scholar
• CogolloESilvaMAIsenbergDProfile of atacicept and its potential in the treatment of systemic lupus erythematosusDrug Des Devel Ther2015913311339
   PubMed Web of Science ®Google Scholar
• LenertANiewoldTBLenertPSpotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to dateDrug Des Devel Ther201711747757
   PubMed Web of Science ®Google Scholar
• HannahJCasianAD’CruzDTacrolimus use in lupus nephritis: a systematic review and meta-analysisAutoimmun Rev20161519310126427983
   PubMed Web of Science ®Google Scholar
• MokCCCalcineurin inhibitors in systemic lupus erythematosusBest Pract Res Clin Rheumatol201731342943829224682
   PubMed Web of Science ®Google Scholar
• TanakaHJohKImaizumiTTreatment of pediatric-onset lupus nephritis: a proposal of optimal therapyClin Exp Nephrol201721575576328258497
   PubMed Web of Science ®Google Scholar
• TakeiSMaenoNShigemoriMClinical features of Japanese children and adolescents with systemic lupus erythematosus: results of 1980–1994 surveyActa Paediatr Jpn19973922502569141267
   PubMedGoogle Scholar
• BertsiasGKTektonidouMAmouraZJoint European League against rheumatism and European renal Association-European dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisAnn Rheum Dis201271111771178222851469
   PubMed Web of Science ®Google Scholar
• HoganJAppelGBUpdate on the treatment of lupus nephritisCurr Opin Nephrol Hypertens201322222423023328501
   PubMed Web of Science ®Google Scholar
• YapDYHChanTMLupus nephritis in Asia: clinical features and managementKidney Dis201512100109
   Web of Science ®Google Scholar
• SinghJAHossainAKotbAWellsGAComparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysisSyst Rev20165115527619512
   PubMedGoogle Scholar
• MokCCTherapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosusExpert Rev Clin Immunol2017131354127417340
   PubMed Web of Science ®Google Scholar
• AnderssonJNagySGrothCGAnderssonUEffects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell levelImmunology19927511361421371491
   PubMed Web of Science ®Google Scholar
• SinghJAHossainAKotbATreatments for lupus nephritis: a systematic review and network MetaanalysisJ Rheumatol201643101801181527585688
   PubMed Web of Science ®Google Scholar
• BaoHLiuZHXieHLHuWXZhangHTLiLSSuccessful treatment of class V+IV lupus nephritis with multitarget therapyJ Am Soc Nephrol200819102001201018596121
   PubMed Web of Science ®Google Scholar
• ChenWTangXLiuQShort-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: a multicenter randomized clinical trialAm J Kidney Dis201157223524421177013
   PubMed Web of Science ®Google Scholar
• HongRHaijinYXianglinWCuilanHNanCHongRA preliminary study of tacrolimus versus cyclophosphamide in patients with diffuse proliferative lupus nephritisNephrol Dial Transplant200722Suppl 627616963476
   PubMed Web of Science ®Google Scholar
• LiXRenHZhangQMycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritisNephrol Dial Transplant20122741467147221917733
   PubMed Web of Science ®Google Scholar
• LiuZZhangHLiuZMultitarget therapy for induction treatment of lupus nephritis: a randomized trialAnn Intern Med20151621182625383558
   PubMed Web of Science ®Google Scholar
• MokCCYingKYYimCWTacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-upAnn Rheum Dis2016751303625550339
   PubMed Web of Science ®Google Scholar
• WangSLiXQuLTacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort studyLupus20122191025103522570338
   PubMed Web of Science ®Google Scholar
• XuALuJLiangYProspective study of tacrolimus in induction trerapy of lupus nephritisJ Sun Yat-Sen Univ2007286683687
   Google Scholar
• YapDYYuXChenXMPilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndromeNephrology201217435235722295934
   PubMed Web of Science ®Google Scholar
• ZhangHHuWXieHTacrolimus versus intravenous cyclophosphamide in the induction therapy of diffuse proliferative lupus nephritisJ Nephrol Dialy Transplant2006156501506
   Google Scholar
• ZhangHHuWXieHRandomized controlled trial of tacrolimus versus intravenous cyclophosphamide in the induction trerapy of class V plus IV lupus nephritisJ Nephrol Dialy Transplant2006156508514
   Google Scholar
• MiyasakaNKawaiSHashimotoHEfficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter studyMod Rheumatol200919660661519688181
   PubMed Web of Science ®Google Scholar
• SakaiRKurasawaTNishiEEfficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in JapanLupus201827227328228683654
   PubMed Web of Science ®Google Scholar
• ChenYSunJZouKYangYLiuGTreatment for lupus nephritis: an overview of systematic reviews and meta-analysesRheumatol Int20173771089109928493175
   PubMed Web of Science ®Google Scholar
• KraaijTBredewoldOWTrompetSTAC-TIC use of tacrolimus-based regimens in lupus nephritisLupus Sci Med201631e00016928123768
   PubMedGoogle Scholar
• JesusDRodriguesMda SilvaJAPInêsLMultitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritisLupus20182781358136229448882
   PubMed Web of Science ®Google Scholar
• BaoJGaoSWengYZhuJYeHZhangXClinical efficacy of tacrolimus for treating myasthenia gravis and its influence on lymphocyte subsetsRev Neurol20191751–2657230293884
   PubMed Web of Science ®Google Scholar
• MadondoMTQuinnMPlebanskiMLow dose cyclophosphamide: mechanisms of T cell modulationCancer Treat Rev2016423926620820
   PubMed Web of Science ®Google Scholar